Why Switch to Generic Icatibant Injection?

Brand vs. Generic – A Sensible and Effective Treatment Option

Icatibant Injection is FDA-approved, so patients can be assured it is made with quality ingredients and is safe and effective. Fresenius Kabi’s generic option uses the same active ingredient as Firazyr®*, has the same intended use, and is also administered subcutaneously.


Fresenius Kabi’s Icatibant Injection Is Fully Substitutable and Chemically Equivalent to Firazyr®*

*FIRAZYR® is a registered trademark of Shire, a Takeda company.

Why Switch to Generic Icatibant Injection?

  • It’s less expensive
  • It’s safe
  • It’s effective
  • It’s convenient
  • It’s from a trustworthy company that uses quality ingredients

Patient Support May Be Available for Eligible Patients

An important part of a successful Hereditary angioedema (HAE) treatment plan is support. Many patients have the support of their family, friends, and care team. Fresenius Kabi, a global healthcare company, developed KabiCare Patient Support Program. The KabiCare Patient Support Program offers financial assistance. Subject to eligibility requirements; available for both commercially insured and patients with no insurance coverage.

Why Trust Fresenius Kabi?

Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion, clinical nutrition, and specialty pharmaceuticals. Our products and programs are designed to help care for critically and chronically ill patients.

Learn more about Fresenius Kabi


References

*FIRAZYR® is a registered trademark of Shire, a Takeda company.